StonvexLoading…
StonvexStonvexStonvexCore line items from BSM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-03 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $107.67M | $123.91M | $422.33M | $327.15M | $221.96M |
Operating Income | Not available | $16.64M | $308.40M | $233.54M | $139.44M |
Net Income | Not available | $13.27M | $299.93M | $227.71M | $135.98M |
EPS (Diluted) | $0.21 | Not available | Not available | Not available | Not available |
Total Assets | Not available | $1.34B | $1.34B | $1.27B | $1.27B |
Total Liabilities | Not available | $264.73M | $207.10M | $145.17M | $165.27M |
Cash & Equivalents | Not available | $11.61M | $1.48M | $2.86M | $2.52M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available | Not available |
Shares Outstanding | Not available | Not available | Not available | Not available | Not available |